To test this, we knocked out the endogenous SLAMF6 expression in KG-1 and HNT-34 AML cells by CRISPR–Cas9 using two different guide RNAs (Fig. 3a, b). This evidence concerns the gene SLAMF6 and acute myeloid leukemia.